Oncology Clinical Trials

Physician’s Weekly has developed an innovative, peer-led initiative designed to transform the way oncologists engage with clinical trials.

A Call for Broader Trial Criteria to Better Match Real-World NSCLC Populations
Researchers found that eligibility criteria for KRAS G12C inhibitor trials in NSCLC exclude most real-world patients.

Relevant Articles